A significant increase in the incidence of allergy and asthma has been observed during the past decades. The background of this phenomenon has not been well explained, but changes in lifestyle and habits are heavily discussed as contributing factors. Among these is a too clean environment, which may predispose individuals to increased sensitivity to allergic responses. Also the increase in dietary supplements including preservatives and colorants may contribute to this. In vitro, we and others have shown in freshly isolated human peripheral blood mononuclear cells that antioxidant compounds like vitamins C and E as well as food preservatives and colorants exert significant suppressive effects on the Th1 immune activation cascade. The effects observed may be based on the interaction of antioxidant compounds with proinflammatory cascades involving important signal transduction elements such as nuclear factor-ĸB. Although only obtained in vitro, these results show an anti-inflammatory property of compounds which could shift the Th1-Th2-type immune balance towards Th2-type immunity. This review article discusses the potential role of increased use of antioxidant food supplements as well as preservatives and colorants in the increase in allergy and asthma in the Western world.

Keywords:
Allergy, Asthma, Immunomodulation, Antioxidants, Food preservatives, Food colorants
1.
von Pirquet C: Allergie. Munch Med Wochenschr 1906;53:1457.
2.
Platts-Mills TA, Erwin E, Heymann P, Woodfolk J: Is the hygiene hypothesis still a viable explanation for the increased prevalence of asthma? Allergy 2005;60(suppl 79):25–31.
3.
O’Connell EJ: The burden of atopy and asthma in children. Allergy 2004;59(suppl 78):7–11.
4.
Chu HW, Lloyd CM, Karmaus W, Maestrelli P, Mason P, Salcedo G, Thaikoottathil J, Wardlaw AJ: Developments in the field of allergy in 2009 through the eyes of clinical and experimental allergy. Clin Exp Allergy 2010;40:1611–1631.
5.
Arbes SJ Jr, Gergen PJ, Elliott L, Zeldin DC: Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol 2005;116:377–383.
6.
Galli SJ: Allergy. Curr Biol 2000;10:R93–R95.
7.
Isolauri E, Huurre A, Salminen, Impivaara O: The allergy epidemic extends beyond the past few decades. Clin Exp Allergy 2006;34:1007–1010.
8.
Durham SR, Till SJ, Corrigan CJ: T lymphocytes in asthma: bronchial versus peripheral responses. J Allergy Clin Immunol 2000;106:S221–S226.
9.
Will-Karp M: Interleukin-13 in asthma pathogenesis. Curr Allergy Asthma Rep 2004;4:123–131.
10.
Strachan DP: Hay fever, hygiene, and household size. BMJ 1989;299:1259–1260.
11.
Sheik A, Strachan DP: The hygiene theory: fact or fiction? Curr Opin Otolaryngol Head Neck Surg 2004;12:232–236.
12.
Gibsen PG, Henry RL, Shah S, Powell H, Wang H: Migration to a Western country increases asthma symptoms but no eosinophilic airway inflammation. Pediatr Pulmonol 2003;36:209–215.
13.
Kozyrskyj AL, Ernst P, Becker AB: Increased risk of childhood asthma from antibiotic use in early life. Chest 2007;131:1753–1759.
14.
Zock JP, Plana E, Jarvis D, Antó JM, Kromhout H, Kennedy SM, Künzli N, Villani S, Olivieri M, Torén K, Radon K, Sunyer J, Dahlman-Hoglund A, Norbäck D, Kogevinas M: The use of household cleaning sprays and adult asthma: an international longitudinal study. Am J Respir Crit Care Med 2007;176:735–741.
15.
Kay AB: Overview of allergy and allergic diseases: with a view to the future. Br Med Bull 2000;56:843–864.
16.
Folkerts G, Walzl G, Openshaw PJ: Do common childhood infections ‘teach’ the immune system not to be allergic? Immunol Today 2000;3:118–120.
17.
Guarner F: Hygiene, microbial diversity and immune regulation. Curr Opin Gastroenterol 2007;23:667–672.
18.
Sly PD: The early origins of asthma: who is really at risk? Curr Opin Allergy Clin Immunol 2011;11:24–28.
19.
Gershwin ME, Borchers AT, Keen CL, Hendler S, Hagie F, Greenwood MR: Public safety and dietary supplementation. Ann NY Acad Sci 2010;1190:104–117.
20.
Simon RA: Adverse reactions to food additives. N Engl Reg Allergy Proc 1986;7:533–542.
21.
Romagnani S: Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol 2004;113:395–400.
22.
Lucey DR, Clerici M, Shearer GM: Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev 1996;94:532–562.
23.
Murr C, Schroecksnadel K, Winkler C, Ledochowski M, Fuchs D: Antioxidants may increase the probability of developing allergic diseases and asthma. Med Hypotheses 2005;64:973–977.
24.
Brown JM, Wilson TM, Metcalfe DD: The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin Exp Allergy 2008;38:4–18.
25.
Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W, Versalovic J, Weinstock JV, Rook GA: Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol 2006;3:275–284.
26.
Lloyd CM, Hessel EM: Functions of T cells in asthma: more than just TH2 cells. Nat Rev Immunol 2010;10:838–848.
27.
Bettelli E, Korn T, Kuchroo VK: Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 2007;19:652–657.
28.
Robinson DS: Regulatory T cells and asthma. Clin Exp Allergy 2009;39:1314–1323.
29.
Stockinger B, Veldhoena M: Differentiation and function of Th17 T cells. Curr Opin Immunol 2007;19:281–286.
30.
Cosmi L, Liotta F, Maggi E, Romagnani S, Annunziato F: Th17 cells: new players in asthma pathogenesis. Allergy 2011;66:989–998.
31.
Wakashin H, Hirose K, Maezawa Y, Kagami S, Suto A, Watanabe N, Saito Y, Hatano M, Tokuhisa T, Iwakura Y, Puccetti P, Iwamoto I, Nakajima H: IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 2008;178:1023–1032.
32.
Pejman S, Taylor AD: Th9 and allergic disease. Immunology 2009;127:450–458.
33.
Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F: CD4+CD25+ TR cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003;197:111–119.
34.
Pasare C, Medzhitov R: Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003;299:1033–1036.
35.
Karlsson MR, Rugtveit J, Brandtzaeg P: Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow’s milk allergy. J Exp Med 2004;199:1679–1688.
36.
Sletten GB, Halvorsen R, Egaas E, Halstensen TS: Memory T cell proliferation in cow’s milk allergy after CD25+ regulatory T cell removal suggests a role for casein-specific cellular immunity in IgE-mediated but not in non-IgE-mediated cow’s milk allergy. Int Arch Allergy Immunol 2007;142:190–198.
37.
Davies K: Oxidative stress, the paradox of aerobic life. Biochem Soc Symp 1995;61:1–31.
38.
Nathan CF, Murray HW, Wiebe ME, Rubin BY: Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 1983;158:670–689.
39.
Nathan CF: Secretory products of macrophages. J Clin Invest 1987;79:319–326.
40.
Schreck R, Albermann K, Baeuerle P: Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 1992; 17:221–237.
41.
Blackwell T, Christman J: The role of nuclear factor-ĸB in cytokine gene regulation. Am J Respir Cell Mol Biol 1997;17:3–9.
42.
Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine, ed 4. Oxford, Clarendon, 2007.
43.
Halliwell B: Oxidative stress and neurodegeneration: where are we now? J Neurochem 2006;97:1634–1658.
44.
Libby B, Ridker PM, Masari A: Inflammation and atherosclerosis. Circulation 2002;105:1135–1143.
45.
Salmon AB, Richardson A, Pérez VI: Update on the oxidative stress theory of aging: does oxidative stress play a role in aging or healthy aging? Free Radic Biol Med 2010;48:642–655.
46.
Halliwell B: Antioxidant defence mechanism: from the beginning to the end (of the beginning). Free Radic Res 1999;31:261–272.
47.
Halliwell B, Rafter J, Jenner A: Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct and indirect effects? Antioxidant or not? Am J Clin Nutr 2005;81:268S–276S.
48.
Siess H: Oxidative stress: oxidants and antioxidants. Exp Physiol 1997;82:291–295.
49.
Balsano C, Alisi A: Antioxidant effects of natural bioactive compounds. Curr Pharm Des 2009;15:3063–3073.
50.
Germann J: Food processing and lipid oxidation. Adv Exp Med Biol 1999;459:23–50.
51.
Knight J: Food processing and lipid oxidation: their history and current status in aging and disease. Ann Clin Lab Sci 1999;28:331–346.
52.
Cao G, Alessio HM, Cutler RG: Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med 1993;14:303–311.
53.
Heidemann C, Schulze MB, Franco OH, van Dam RM, Mantzoros CS, Hu FB: Dietary patterns and risk of mortality from cardiovascular disease, cancer, and all causes in a prospective cohort of women. Circulation 2008;118:230–237.
54.
Stanner SA, Hughes J, Kelly CN, Buttriss J: A review of epidemiological evidence of the antioxidant hypothesis. Public Health Nutr 2004;7:407–422.
55.
Aggarwal BB, Shishodia S: Suppression of the nuclear factor-ĸB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann NY Acad Sci 2004;1030:434–441.
56.
Vally H, Misso NL, Madan V: Clinical effects of sulphite additives. Clin Exp Allergy 2009;39:1643–1651.
57.
Cai Y, Sun M, Corke H: Antioxidant activity of betalains from plants of the amaranthaceae. J Agric Food Chem 2003;51:2288–2294.
58.
Griendling KK, Fitzgerald GA: Oxidative stress and cardiovascular injury. Part 2. Animal and human studies. Circulation 2003;108:2034–2040.
59.
Murr C, Winklhofer-Roob BM, Schroecksnadel K, Maritschnegg M, Mangge H, Böhm BO, Winkelmann BR, März W, Fuchs D: Inverse association between serum concentrations of neopterin and antioxidants in patients with and without angiographic coronary artery disease. Atherosclerosis 2009;202:543–549.
60.
Rahman I, Biswas SK: Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues. Redox Rep 2004;9:125–143.
61.
Montuschi P, Barnes P, Roberts JJ 2nd: Insights into oxidative stress: the isoprostanes. Curr Med Chem 2007;14:703–717.
62.
Fuchs D, Shearer GM, Boswell RN, Clerici M, Reibnegger G, Werner ER, Zajac RA, Wachter H: Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production. Clin Exp Immunol 1990;80:44–48.
63.
Murr C, Widner B, Wirleitner B, Fuchs D: Neopterin as a marker for immune system activation. Curr Drug Metabol 2002;3:175–187.
64.
Schroecksnadel K, Wirleitner B, Winkler C, Fuchs D: Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 2006;364:82–90.
65.
Weiss G, Murr C, Zoller H, Haun M, Widner B, Ludescher C, Fuchs D: Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells. Clin Exp Immunol 1999;116:435–440.
66.
Nathan CF: Peroxide and pteridine: a hypothesis on the regulation of macrophage antimicrobial activity by interferon gamma. Interferon 1986;7:125–143.
67.
Schroecksnadel S, Jenny M, Kurz K, Klein A, Ledochowski M, Überall F, Fuchs D: LPS-induced NF-ĸB expression in THP-1Blue cells correlates with neopterin production and activity of indoleamine 2,3-dioxygenase. Biochem Biophys Res Com 2010;399:642–646.
68.
Hronek M, Zadak Z, Solichova D, Jandik P, Melichar B: The association between specific nutritional antioxidants and manifestation of colorectal cancer. Nutrition 2000;16:189–191.
69.
Murr C, Schroecksnadel K, Winkler C, Ledochowski M, Fuchs D: Antioxidants may increase the probability of developing allergic diseases and asthma. Med Hypotheses 2005;64:973–977.
70.
Schroecksnadel K, Fischer B, Schennach H, Weiss G, Fuchs D: Antioxidants suppress Th1-type immune response in vitro. Drug Metab Lett 2007;1:166–171.
71.
Jenny M, Klieber M, Zaknun D, Schroecksnadel S, Kurz K, Ledochowski M, Schennach H, Fuchs D: In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors. Inflamm Res 2010;60:127–135.
72.
Schroecksnadel S, Maier E, Jenny M, Kurz K, Überall F, Fuchs D: Beeinflussung immunologischer Regelkreise durch Nahrungsmittelzusatzstoffe wie Konservierungsmittel und Farbstoffe in vitro. Allergologie 2011;34:200–211.
73.
Gruber A, Murr C, Wirleitner B, Werner-Felmayer G, Fuchs D: Histamine suppresses neopterin production in the human myelomonocytoma cell line THP-1. Immunol Lett 2000;72:133–136.
74.
Winkler C, Schroecksnadel K, Schennach H, Fuchs D: Vitamin C and E suppress mitogen-stimulated peripheral blood mononuclear cells in vitro. Int Arch Allergy Immunol 2007;142:127–132.
75.
Tan PH, Sagoo P, Chan C, Yates JB, Campbell J, Beutelspacher SC, Foxwell BM, Lombardi G, George AJ: Inhibition of NF-ĸB and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J Immunol 2005;174:7633–7644.
76.
Jyonouchi H, Sun S, Mizokami M, Gross MD: Effects of various carotenoids on cloned, effector-stage T-helper cell activity. Nutr Cancer 1996;26:313–324.
77.
Snel J, Born L, van der Meer R: Dietary fish oil impairs induction of γ-interferon and delayed-type hypersensitivity during a systemic Salmonella enteritidis infection in rats. APMIS 2010;118:578–584.
78.
Schroecksnadel K, Winkler C, Wirleitner B, Schennach H, Fuchs D: Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro. Clin Exp Immunol 2005;140:41–45.
79.
Kuhn W, Müller T, Büttner T, Gerlach M: Aspirin as a free radical scavenger: consequences for therapy of cerebrovascular ischemia. Stroke 1995;26:1959–1960.
80.
Dragomir E, Manduteanu I, Voinea M, Costache G, Manea A, Simionescu M: Aspirin rectifies calcium homeostasis, decreases reactive oxygen species, and increases NO production in high glucose-exposed human endothelial cells. J Diabetes Complications 2004;18:289–299.
81.
Jenkins C, Costello J, Hodge L: Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 2004;328:434.
82.
Maskos Z, Rush JD, Koppenol WH: The hydroxylation of the salicylate anion by a Fenton reaction and T-radiolysis: a consideration of the respective mechanisms. Free Radic Biol Med 1990;8:153–162.
83.
Ionescu JG: New insights in the pathogenesis of atopic disease. J Med Life 2009;2:146–154.
84.
Ozol D, Mete E: Asthma and food allergy. Curr Opin Pulm Med 2008;14:9–12.
85.
Madan V, Walker SL, Beck MH: Sodium metabisulfite allergy is common but is it relevant? Contact Dermatitis 2007;57:173–176.
86.
Lucas JS, Lewis SA, Hourihane JO: Kiwi fruit allergy: a review. Pediatr Allergy Immunol 2003;14:420–428.
87.
Roehr CC, Edenharter G, Reimann S, Ehlers I, Worm M, Zuberbier T, Niggemann B: Food allergy and non-allergic food hypersensitivity in children and adolescents. Clin Exp Allergy 2004;34:1534–1541.
88.
Bakolis I, Hooper R, Thompson RL, Shaheen SO: Dietary patterns and adult asthma: population-based case-control study. Allergy 2010;65:606–615.
89.
Nagel G, Nieters A, Becker N, Linseisen J: The influence of the dietary intake of fatty acids and antioxidants on hay fever in adults. Allergy 2003;58:1277–1284.
90.
Szczeklik A: Adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. Ann Allergy 1987;59:113–118.
91.
Ledochowski M, Murr C, Widner B, Fuchs D: Inverse relationship between neopterin and immunoglobulin E. Clin Immunol 2001;98:104–108.
92.
von Bubnoff D, Fimmers R, Bogdanow M, Matz H, Koch S, Bieber T: Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clin Exp Allergy 2004;34:1056–1063.
93.
Raitala A, Karjalainen J, Oja SS, Kosunen TU, Hurme M: Indoleamine 2,3-dioxygenase (IDO) activity is lower in atopic than in non-atopic individuals and is enhanced by environmental factors protecting from atopy. Mol Immunol 2006;43:1054–1056.
94.
Kositz C, Schroecksnadel K, Grander G, Schennach H, Kofler H, Fuchs D: Serum tryptophan concentration in patients predicts outcome of specific immunotherapy with pollen extracts. Int Arch Allergy Immunol 2008;147:35–40.
95.
Ciprandi G, Amici M, Tosca M, Fuchs D: Tryptophan metabolism in allergic rhinitis: the effect of pollen allergen exposure. Hum Immunol 2010;71:911–915.
96.
Romani L, Zelante T, de Luca A, Bozza S, Bonifazi P, Moretti S, D’Angelo C, Giovannini G, Bistoni F, Fallarino F, Puccetti P: Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy to Aspergillus. Med Mycol 2009;47(suppl 1):S154–S161.
97.
Yan Y, Zhang GX, Gran B, Fallarino F, Yu S, Li H, Cullimore ML, Rostami A, Xu H: IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J Immunol 2010;185:5953–5961.
98.
Werner ER, Bitterlich G, Fuchs D, Hausen A, Reibnegger G, Szabo G, Dierich MP, Wachter H: Human macrophages degrade tryptophan upon induction by interferon-γ. Life Sci 1987;41:273–280.
99.
Pae HO, Chung HT: Heme oxygenase-1: its therapeutic roles in inflammatory diseases. Immune Netw 2009;9:12–19.
100.
Ristow M, Zarse K, Oberbach A, Klöting N, Birringer M, Kiehntopf M, Stumvoll M, Kahn CR, Blüher M: Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA 2009;106:8665–8670.
101.
Wong GW, Ko FW, Hui DS, Fok TF, Carr D, von Mutius E, Zhong NS, Chen YZ, Lai CK: Factors associated with difference in prevalence of asthma in children from three cities in China: multicentre epidemiological survey. BMJ 2004;329:486.
102.
Chen S, Gong J, Liu F, Mohammed U: Naturally occurring polyphenolic antioxidants modulate IgE-mediated mast cell activation. Immunology 2000;100:471–480.
103.
Casillas AM, Hiura T, Li N, Nel AE: Enhancement of allergic inflammation by diesel exhaust particles: permissive role of reactive oxygen species. Ann Allergy Asthma Immunol 1999;83:624–629.
104.
Hansen G, Berry G, DeKruyff RH, Umetsu DT: Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999;103:175–183.
105.
Yang Y, Paik JH, Cho D, Cho JA, Kim CW: Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells. Int Immunopharmacol 2008;8:542–547.
106.
Yan Z, Garg SK, Banerjee R: Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells. J Biol Chem 2010;285:41525–41532.
107.
Schwartz JL: The dual roles of nutrients as antioxidants and prooxidants: their effects on tumor cell growth. J Nutr 1996;126(suppl 4):S1221–S1227.
108.
Boileau TW, Liao Z, Kim S, Lemeshow S, Erdman JW Jr, Clinton SK: Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J Natl Cancer Inst 2003;95:1578–1586.
109.
Clement MV, Ramalingam J, Long LH, Halliwell B: The in vitro cytotoxicity of ascorbate depends on the culture medium used to perform the assay and involves hydrogen peroxide. Antioxid Redox Signal 2001;3:157–163.
110.
Karin M, Greten FR: NF-ĸB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005;5:749–759.
111.
Seifried HE, Anderson DE, Fisher EI, Milner JA: A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem 2007;18:567–579.
112.
Brandtzaeg P: Food allergy: separating the science from the mythology. Nat Rev Gastroenterol Hepatol 2010;7:380–400.
113.
Cianferoni A, Spergel JM: Food allergy: review, classification and diagnosis. Allergol Int 2009;58:457–466.
114.
Osterballe M, Mortz CG, Hansen TK, Andersen KE, Bindslev-Jensen C: The prevalence of food hypersensitivity in young adults. Pediatr Allergy Immunol 2009;20:686–692.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.